BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35168698)

  • 21. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.
    Lee TK; Man K; Poon RT; Lo CM; Yuen AP; Ng IO; Ng KT; Leonard W; Fan ST
    Cancer Res; 2006 Oct; 66(20):9948-56. PubMed ID: 17047057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.
    Liang HW; Wang N; Wang Y; Wang F; Fu Z; Yan X; Zhu H; Diao W; Ding Y; Chen X; Zhang CY; Zen K
    J Hepatol; 2016 Feb; 64(2):278-291. PubMed ID: 26409216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
    Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
    Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
    Chen JY; Chen YJ; Yen CJ; Chen WS; Huang WC
    Oncotarget; 2016 Jan; 7(1):473-89. PubMed ID: 26595522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
    Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
    Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
    Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma.
    Bock CT; Toan NL; Koeberlein B; Song le H; Chin R; Zentgraf H; Kandolf R; Torresi J
    Intervirology; 2008; 51(6):432-43. PubMed ID: 19321929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus X protein enhances liver cancer cell migration by regulating calmodulin-associated actin polymerization.
    Kim MJ; Kim J; Im JS; Kang I; Ahn JK
    BMB Rep; 2021 Dec; 54(12):614-619. PubMed ID: 34488928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis.
    Chen SL; Liu LL; Lu SX; Luo RZ; Wang CH; Wang H; Cai SH; Yang X; Xie D; Zhang CZ; Yun JP
    Mol Oncol; 2017 Sep; 11(9):1225-1240. PubMed ID: 28580773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
    Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
    Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
    Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
    Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma.
    Gao Q; Wang K; Chen K; Liang L; Zheng Y; Zhang Y; Xiang J; Tang N
    Cancer Sci; 2017 Jul; 108(7):1328-1337. PubMed ID: 28498550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
    Chen S; Dong Z; Yang P; Wang X; Jin G; Yu H; Chen L; Li L; Tang L; Bai S; Yan H; Shen F; Cong W; Wen W; Wang H
    Cancer Lett; 2017 May; 394():22-32. PubMed ID: 28216372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
    Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
    BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression.
    Zheng C; Liu M; Ge Y; Qian Y; Fan H
    Cell Death Dis; 2022 Feb; 13(2):116. PubMed ID: 35121725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
    Fan H; Zhang H; Pascuzzi PE; Andrisani O
    Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.